FindTrial
Sign In

Study for comparison of bupivacaine alone bupivacaine plus dexmedetomidine and bupivacaine plus magnesium sulfate for prevention of shivering after spinal anaesthesia in prostate surgery.

A comparative study to assess the efficacy and safety of intrathecal bupivacaine alone, intrathecal bupivacaine plus dexmedetomidine and intra thecal bupivacaine plus magnesium sulfate for the prevention of post spinal anaesthesia shivering in transurethral resection of prostate(TURP)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030305
Enrollment
75
Registered
2021-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Central neuraxial block - spinal anaesthesia: The comparative agents are given in the sub-arachnoid space via spinal needle using LOR technique to assess the efficacy and safety in prev

Sponsors

Dr SN Medical college and associated group of hospitals Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male patients of ASA grade I and II of age 18-60 years posted for transurethral resection of prostate suitable for administration of regional anaesthesia

Exclusion criteria

Exclusion criteria: Patients refusal, BMI >28.0, spinal abnormality, patients with CKD, any contraindication to spinal anaesthesia like sepsis, abnormal coagulation profile, emergency surgery, infection at site of injection, allergy to local anaesthetics

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of intrathecal bupivacaine alone, bupivacaine plus dexmedetomidine and bupivacaine plus magnesium sulfate group in terms of incidence and intensity of shiveringTimepoint: 3 Months—

Secondary

MeasureTime frame
To compare the safety of intrathecal bupivacaine alone, bupivacaine plus dexmedetomidine and bupivacaine plus magnesium sulfate group in terms of hypothermia sedation score and complication including hypotension, bradycardia, nausea, vomiting and total dose of pethidine required to control shiveringTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Sunil Kumar Saharan

Dr S.N. Medical Jodhpur

takml88@gmail.com9309087757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026